ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.205
+0.105 (5.00%)
At close: Dec 19, 2025, 4:00 PM EST
2.210
+0.005 (0.23%)
After-hours: Dec 19, 2025, 4:10 PM EST

ProQR Therapeutics Revenue

ProQR Therapeutics had revenue of 2.88M EUR in the quarter ending September 30, 2025, a decrease of -25.01%. This brings the company's revenue in the last twelve months to 15.53M, down -13.18% year-over-year. In the year 2024, ProQR Therapeutics had annual revenue of 18.91M with 190.22% growth.

Revenue (ttm)
15.53M EUR
Revenue Growth
-13.18%
P/S Ratio
12.17
Revenue / Employee
93,468 EUR
Employees
166
Market Cap
232.81M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202418.91M12.39M190.22%
Dec 31, 20236.51M2.92M81.25%
Dec 31, 20223.59M2.26M169.21%
Dec 31, 20211.34M-8.12M-85.88%
Dec 31, 20209.45M7.52M388.98%
Dec 31, 20191.93M-3.83M-66.45%
Dec 31, 20185.76M4.27M285.35%
Dec 31, 20171.50M-333.00K-18.22%
Dec 31, 20161.83M-1.41M-43.49%
Dec 31, 20153.24M2.92M933.55%
Dec 31, 2014313.00K197.00K169.83%
Dec 31, 2013116.00K93.00K404.35%
Dec 31, 201223.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings